List of all PATCH Posters

Please find below the list of all PATCH Posters (available on request)

Langley RE, Kynaston H, Clarke NW, Godsland IF, Rosen SD, Morgan RC, Pollock P, Parmar

MK & Abel PD. PATCH, a randomised phase II trial of oestrogen patches versus LHRH as

first-line hormonal therapy for prostate cancer: Planned interim analysis results.

ASCO Genitourinary Cancers Symposium 2009 Abstract #173.

Abel PD, Sundaram SK, Kynaston HG, Clarke N, Alhasso AA, Rosen SD, Jinks RC, Pollock P,

Cafferty FH and Langley RE. Cardiovascular events and clinical responses in prostate cancer

patients treated with transcutaneous oestrogen patches compared with LHRH analogues:

Results from a randomized phase II trial (MRC PR09 PATCH). J Clin Oncol 2011; 29 (suppl

7; abstract 201).

Langley RE, Jinks RC, Sundaram SK, Clarke NC, Kynaston HG, Alhasso AA, Rosen SD,

Kockelbergh R, Parmar MK, Pollock P, Cafferty FH and Abel PD. Hormone responses in

prostate cancer patients treated with transcutaneous oestrogen patches: Results from a

randomised phase II Trial (MRC PR09 PATCH). EAU Annual Congress 2011 Abstract #1097.

Langley RE, Duong T, Jovic G, Alhasso AA, Kynaston H, Dearnaley DP, Rosen SD,

Kockelbergh R, Clarke NW, Godsland IF, Sundaram SK, Dixit S, Laniado M, Stockdale A,

Pope A, Paez EM, Spittle B, Bara A, Parmar MKB, Abel PD. PATCH: A randomised controlled

trial of transdermal oestrogen patches versus luteinising hormone-releasing hormone

agonists in locally advanced and metastatic prostate cancer. J Clin Oncol 2014; 32 (suppl

5; abstr TPS5099).

Langley RE, Duong T, Govic F, Cafferty F, Honeyfield L, Abel RL, Stone M, Kynaston H,

Alhasso AA, Scrase CD, Paez EM, Spittle B, Bara A, Parmar MKB, Abel PD. Bone density in

men receiving androgen deprivation therapy for prostate cancer: A randomised comparison

between transdermal oestrogen and luteinising hormone-releasing hormone agonists.

J Clin Oncol 2014; 32 (suppl 5; abstr 5067).

Posted by PATCH Team on 23 Oct 2019